Rhythm Pharmaceuticals Inc (RYTM)

NASDAQ · Biotechnology

90.78
+1.14 (+1.27%)
Updated Oct 9, 11:06 PM ET
AI Rating
Hold
Overall Score
41
Trend
33
Momentum
31
Risk
69

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Sep 23, 2025 260 sessions Oct 5, 2026

AI Analysis

Rhythm Pharmaceuticals Inc is trading at $90.78, up 1.27% on the session. The 50 day average sits at $105.22 and the 200 day at $98.79, which puts the stock in a uptrend. RSI is at 28.7, which reads as oversold, and MACD is bearish crossover. Volume is above average.

The nearest support is around $89.53 with resistance near $106.57, so that band frames the current range. Average daily movement is roughly $3.83, or about 4.2% of the share price, which is what any stop placement has to allow for. The overall health score of 41 out of 100 combines a trend score of 33, momentum of 31 and a risk score of 69.

Technical indicators

RSI (14)
28.7
oversold
MACD
-3.318
bearish crossover
SMA 20
98.26
SMA 50
105.22
SMA 200
98.79
uptrend
ATR (14)
3.83
avg daily range
Support
89.53
Resistance
106.57
Volume vs 20d
1.45x
above average
Volatility
28.3%
annualised
1 month
-11.86%
3 months
-19.23%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.